tiprankstipranks
Adagene (ADAG)
NASDAQ:ADAG
US Market
ADAG
Adagene
RESEARCH TOOLSreports

Adagene (ADAG) Stock News & Sentiment

110 Followers
Adagene: Deepening Dose‑Response Evidence and Strategic Partnership Support Buy Rating on Lead CTLA‑4 Program
Premium
Ratings
Adagene: Deepening Dose‑Response Evidence and Strategic Partnership Support Buy Rating on Lead CTLA‑4 Program
5d ago
ADAG
Adagene Posts Strong Muzastotug Data and Incyte Collaboration in MSS Colorectal Cancer
Premium
Company Announcements
Adagene Posts Strong Muzastotug Data and Incyte Collaboration in MSS Colorectal Cancer
9d ago
6K
ADAG
Adagene Prices US$70 Million ADS Offering to Bolster Cancer Immunotherapy Pipeline
Premium
Company Announcements
Adagene Prices US$70 Million ADS Offering to Bolster Cancer Immunotherapy Pipeline
9d ago
6K
ADAG
Adagene Posts 2025 Results as Muzastotug Data, Partnerships Extend Cash Runway to 2028
Premium
Company Announcements
Adagene Posts 2025 Results as Muzastotug Data, Partnerships Extend Cash Runway to 2028
9d ago
6K
ADAG
Adagene (ADAG): De-Risked CTLA-4 Asset, Emerging Regulatory Clarity, and Strategic Partnerships Underpin Buy Rating
Premium
Ratings
Adagene (ADAG): De-Risked CTLA-4 Asset, Emerging Regulatory Clarity, and Strategic Partnerships Underpin Buy Rating
2M ago
ADAG
Adagene Outlines 2026 Clinical Milestones and Reports $74.5 Million Year-End Cash Runway
Premium
Company Announcements
Adagene Outlines 2026 Clinical Milestones and Reports $74.5 Million Year-End Cash Runway
3M ago
6K
ADAG
Adagene and Third Arc Bio Forge Licensing Agreement for Cancer Therapy Development
Premium
Company Announcements
Adagene and Third Arc Bio Forge Licensing Agreement for Cancer Therapy Development
5M ago
6K
ADAG
More ADAG News >

ADAG News on the Web

Analysts Offer Insights on Healthcare Companies: Adagene (ADAG), Caribou Biosciences (CRBU) and Praxis Precision Medicines (PRAX)
TipRanks News
Bullish
Guggenheim Keeps Their Buy Rating on Adagene (ADAG)
TipRanks News
Neutral
Adagene: Deepening Dose‑Response Evidence and Strategic Partnership Support Buy Rating on Lead CTLA‑4 Program
TipRanks News
Bullish
Adagene price target raised to $10 from $9 at Guggenheim
TipRanks News
Bullish
Adagene 18.666M share Spot Secondary priced at $3.75
TipRanks News
Neutral
Adagene enters pact with Incyte for combination of muzastotug, INCA33890
TipRanks News
Neutral
Adagene announces results from the latest data cut of muzastotug study
TipRanks News
Bullish
Adagene Posts Strong Muzastotug Data and Incyte Collaboration in MSS Colorectal Cancer
TipRanks News
Neutral

News Score - Last 7 Days

Very Positive
ADAG
Sector Average
Media Buzz
This Week4 articles
Weekly Average2.75 articles
News Sentiment
This Week100%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ADAG’s Media Buzz Sentiment?
4 articles about ADAG were published this week. In an average week, 2.75 articles are published.
    What is ADAG’s weekly average amount of articles?
    In an average week, 2.75 articles about ADAG are published.
      What is ADAG’s News Sentiment?
      100% of articles about ADAG were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        AORTArtivion
        NBIXNeurocrine
        STAAStaar Surgical
        SLPSimulations Plus
        OWLTOwlet
        Showing the stocks with the most bullish news sentiment over the past week